Neogen Chemicals Ltd. · NSE:NEOGEN
Neogen Chemicals — Q1 FY2021 Earnings Presentation
17 slides from Neogen Chemicals's earnings presentation, Aug 8, 2020
Slide 1: Neogen Chemicals Ltd. Q1 FY21 Earnings Presentation
Neogen Chemicals Ltd. Q1 FY21 Earnings Presentation August 2020
Slide 2: Safe Harbour
Safe Harbour 2 Certain statements in this document may be forward-looking statements. Such forward looking statements are subject to certain risks and uncertainties like regulatory changes, local political or economic developments, and many other factors that could cause our actual results to differ
Slide 3: Table of Contents
Table of Contents 3 4 6 7 13 14 15 16 30 Introduction Q1 FY21 Historical Competitive Management Way to Neogen Financial Financial Contact Us Advantages Commentary Forward Chemicals Performance Trends
Slide 4: Neogen Chemicals – At a Glance
Neogen Chemicals – At a Glance 4 Leading manufacturer of Bromine and Lithium-based specialty chemicals, operating since 1991 Products developed Of workforce in Strong portfolio of Organic and Inorganic products by in-house R&D R&D team Customers across multiple industries including Pharma, Engineeri
Slide 5: Business Overview and Clientele
Business Overview 5 Organic Chemicals Inorganic Chemicals The portfolio includes specialty, inorganic Custom Synthesis & lithium-based chemical products which Bromine Compounds Advanced Intermediates Manufacturing find applications across multiple industries Organic compounds containing Combining br
Slide 6: Competitive Advantages
Competitive Advantages 6 Large and diverse array of products Strong Manufacturing Capabilities Experienced promoters with domain knowledge Diversified and Stable Established and stable Customer Base relationship with suppliers Specialised Business Model Continuous Investment with high entry barriers
Slide 7: Key Performance Highlights – Q1 FY21
Key Performance Highlights – Q1 FY21 7 Q1 FY21 Rs. 77 crore 19% Q1 FY21 Revenue Revenues break-up Rs. 14 crore* 18% 38% 62% EBITDA Rs. 9 crore* 18% Profit Before Tax Domestic *Exports Rs. 6 crore* 12% *Including deemed exports Profit After Tax Note: 1. Growth for Q1 FY21 is compared to Q1 FY20 2. Al
Slide 8: Financial Summary – Q1 FY21
Financial Summary – Q1 FY21 8 REVENUE EBITDA PAT 76.6 13.6 6.1 64.4 11.5 5.5 Q1FY20 Q1FY21 Q1FY20 Q1FY21 Q1FY20 Q1FY21 Rs. crore Rs. crore Rs. crore • Reported strong performance driven by positive demand Despite shutdown impact in the scenario; growth could have initial period of the quarter, Highe
Slide 9: Revenue break-up – Q1 FY21
Revenue break-up – Q1 FY21 9 Q1 FY21 Q1 FY20 36% Rs. 66 crore Rs. 48 crore Organic Chemicals 33% Rs. 11 crore Rs. 16 crore Inorganic Chemicals
Slide 10: Ongoing impact/ update due to CoVID-19
Ongoing impact/ update due to CoVID-19 10 • There is no significant impact of CoVID-19 pandemic on the current and future business condition of the Company, its liquidity position and its cash flow • After obtaining requisite permissions from concerned Government authorities, the Company resumed pro
Slide 11: Seasonal Variance Factors
Seasonal Variance Factors 11 • Neogen’s business has some seasonal drivers, due to which the company tends to deliver stronger financial performance in the second half of the financial year (October to March). Seasonal variance is driven by strong demand from Europe as orders tend to scale up in Oct
Slide 12: Financial Table – Profit & Loss Statement (Standalone)
Financial Table – Profit & Loss Statement (Standalone) 12 Particulars (Rs. crore) Q1 FY21 Q1 FY20 Growth (%) FY20 Revenue 76.6 64.4 18.9% 306.1 Expenditure 63.0 52.9 19.1% 248.1 EBITDA 13.6 11.5 17.9% 58.1 Margins 17.7% 17.8% 19.0% Depreciation 1.6 0.9 75.3% 5.2 EBIT 12.0 10.6 12.9% 52.8 Interest 3.
Slide 13: Management Commentary
Management Commentary 13 Commenting on the Q1 FY21 performance, Mr. Haridas Kanani, Chairman & Managing Director, at Neogen Chemicals said: “ I would like to thank all our Neogen family members, especially the manufacturing and engineering teams, for working together closely in these challenging con
Slide 14: Historical Financial Trends
Historical Financial Trends 14 Net Revenue from Operations** EBITDA (INR crore) Margin (%) (INR crore) 18.1% 17.8% 18.2% 19.0% 15.0% 14.0% 306 239 163 85 101 111 13 14 20 29 43 58 FY15 FY16 FY17 FY18 FY19 FY20 FY15 FY16 FY17 FY18 FY19 FY20 ** Revenue is Net of Excise PAT (INR crore) Margin (%) Netwo
Slide 15: Way Forward
Way Forward 15 Increasing Custom Synthesis & Manufacturing portfolio Augmenting growth in domestic and global markets Expanding production capacities Focus on advanced speciality intermediates Focus on operational efficiency and functional excellence
Slide 16: Contact Us
Contact Us 16 About Neogen Chemicals Limited For further information, please contact: Incorporated in 1989, Neogen Chemicals Ltd. (NSE Code: NEOGEN; BSE Shiv Muttoo / Nishid Solanki Code: 542665) is one of India’s leading manufacturers of Bromine-based and Lithium-based specialty chemicals. Its spec
Slide 17: Thank You
3 ) a x Sq (qr) = al